On this page
Cost per patient start is the ad spend behind a direct-to-patient program divided by the number of new patients who began therapy in the same period, read by channel, campaign and partner. In a cash-pay program, this page counts a start at a new patient's first paid fill at a partner pharmacy, a step that happens outside the brand site and often outside claims data, so the partner has to report it. With Curve Compliance, telehealth and pharmacy partners can report each step through an incoming webhook or a file upload, with no name or contact details. Those partner-reported steps feed the drugmaker's aggregate reports: Campaign Reporting puts Meta and Google Ads spend next to them by campaign, and the drugmaker receives aggregate results by channel, campaign and partner.
Book a call. Want cost per patient start for your direct-to-patient program? Curve's team can map the steps your partners would report and the aggregate results your brand team would receive. Book a call with Curve.
What is cost per patient start?
It is the acquisition cost of one new patient on therapy. The spend side is what you paid for media in a period. The start side is the number of new patients whose first paid fill is credited to that media. Dividing one by the other gives a number a brand team can set against its media plan, campaign by campaign.
A click, a sign-up or a telehealth visit tells you an ad worked at the top of the funnel. A start tells you a patient began therapy. In a direct-to-patient program those two can be several steps and several days apart, and each step happens in a different system: the brand site, the telehealth partner and the pharmacy.
How is cost per patient start different from cost per paid fill?
Both use the same spend. They differ in what they divide by. A patient start counts each new patient once, at the first paid fill. A paid fill counts every fill a patient pays for, first fills and refills alike. The table puts them next to the earlier funnel metrics a brand team usually sees first.
| Metric | Spend divided by | What it tells the brand team |
|---|---|---|
| Cost per visit | Telehealth visits started | Whether the ads bring people to a partner's intake |
| Cost per consult | Completed consults | Whether visitors go on to see a clinician |
| Cost per prescription | Prescriptions written | Whether consults end in a prescription |
| Cost per patient start | New patients with a first paid fill | What it costs to bring one new patient onto therapy |
| Cost per paid fill | All paid fills, first fills and refills | Whether the patients a campaign brings keep filling |
| Retention at month 3 and month 6 | Not a cost: the share of starts still filling | Whether starts last, read by partner in aggregate |
Read together, these separate campaigns that look alike at the top. Two campaigns can have the same cost per visit and a very different cost per patient start. Two campaigns with the same cost per patient start can drift apart on cost per paid fill once refills come in, because one brings patients who continue and the other brings patients who stop after the first fill.
Why do drugmakers measure patient starts?
Because more of the starts that matter now begin outside the channels brand teams have measured for years. L.E.K. Consulting puts it this way: “When a growing share of new-to-brand prescriptions in select therapeutic classes originates outside traditional channels, brand strategy itself must evolve” (L.E.K. Consulting, 2026).
The industry's own language points at the same number. In the Digital Medicine Society's release launching its direct-to-patient initiative with leading pharma organizations, an executive of founding partner PHIL Inc. said: “Pharmaceutical manufacturers that do this well will see the impact where it matters most: patient starts, adherence, and long-term therapy outcomes” (Digital Medicine Society, April 16, 2026). The initiative itself says it “will also define how to measure patient access and affordability.” Pharmaceutical Commerce, summarizing an interview on direct-to-patient metrics, notes that “evaluating metrics like conversion rates, refill adherence, and integration with other access and affordability programs can reveal the full value of these initiatives” (Pharmaceutical Commerce, March 26, 2026).
Cost per patient start is where those threads meet the media budget. It is the number that says whether a campaign brings patients onto therapy at a cost the program can sustain, and it is the number the brand team will be asked for when the program is reviewed.
Why does claims data miss cash-pay patient starts?
Claims data was built for prescriptions that insurance adjudicates. HealthVerity notes that “Closed claims data has historically been effective for analyzing medication initiation, adherence, persistence, and discontinuation, but only when prescriptions are adjudicated through insurance,” and that “As patients shift to cash-pay options, pharmacy claims may no longer be generated” (HealthVerity, January 14, 2026). A cash-pay start can simply never appear there.
IQVIA makes the same point about the data sources most teams use for obesity, listing “Poor insight into patient access routes, including out-of-pocket purchasing, online pharmacies” among their limits (IQVIA, 2026). For a direct-to-patient program, the start therefore has to come from the partner that records it: the pharmacy that took the payment, or the telehealth partner that saw the patient.
How do you compute cost per patient start, step by step?
- Define a start with every partner. For example, a new patient's first paid fill, with an agreed rule for transfers and restarts. Write the definition down before launch and use the same one at every partner, or the partner numbers won't compare.
- Keep the campaign attached. Curve keeps the ad click attached when a visitor leaves your site for a booking or intake step on another system. That is built in for common booking tools, other systems are connected through setup by Curve's team, and outcomes recorded days later still match.
- Have partners report the steps. A partner can report consults, prescriptions and paid fills through an incoming webhook or a file upload from its CRM or EHR. Each event carries the step, the time and the campaign reference, with no name or contact details, and is credited to the original ad click.
- Pick one attribution model. Campaign Reporting offers five attribution models. Compare campaigns and channels under the same one, or the comparison measures the models rather than the media.
- Put spend next to starts. Campaign Reporting puts Meta and Google Ads spend next to Curve-tracked conversions per platform and campaign. Spend divided by starts credited to it is the campaign's cost per patient start.
- Read it by partner and by start month, then add retention. The same campaign can produce starts at different rates at different partners. Refills at month 3 and month 6, by partner and in aggregate, show whether those starts last.
In words: a campaign's cost per patient start equals its media spend in the period, divided by the new patients whose first paid fill is credited to that campaign under the model you chose. Cost per paid fill uses the same spend, divided by all paid fills credited to the campaign.
What partners may report to a drugmaker, and under which agreement, is settled before launch, so talk to your counsel about the partner agreements before the first event is sent.
What can distort cost per patient start?
- Different definitions. One partner counts a start at the prescription, another at the paid fill. Agree one definition and hold every partner to it.
- Timing. A start can land days after the click. Credit it to the click's campaign and read results by start month, so late starts are counted where they belong.
- Small groups. A campaign or partner with few starts swings from week to week. Set a minimum group size before a number is shown, which also protects patient privacy.
- Mixed spend sources. Compare campaigns using the same spend source and the same attribution window.
- Starts read without refills. A low cost per patient start can hide patients who stop after the first fill. Read it next to cost per paid fill and retention at month 3 and month 6.
None of these is solved by more data. They are solved by agreeing definitions and reporting rules with partners at the start, and keeping them stable for long enough to compare quarters.
How is this different from a clinic's cost per started patient?
A telehealth clinic computes cost per started patient for its own campaigns, from its own EHR, pharmacy or billing records; see how a GLP-1 clinic calculates cost per started patient for that view. A drugmaker's version spans several partners, none of which is the drugmaker. The start comes from each partner's report, and the drugmaker receives aggregate results by channel, campaign and partner.
How Curve Compliance helps
Curve Compliance gives a direct-to-patient program the inputs cost per patient start needs. On the brand site, one script replaces browser ad pixels, and site conversions go server-side to the ad platforms with a fixed list of fields per platform. The ad click stays attached when a visitor moves to a partner's intake step. Separately, partners can report consults, prescriptions and paid fills through an incoming webhook or a file upload, with no name or contact details, and each one is credited to the original ad click.
Those partner-reported steps feed the drugmaker's aggregate reports. Campaign Reporting puts Meta and Google Ads spend next to them per platform and campaign, with five attribution models, so cost per patient start and cost per paid fill can be read by campaign. The drugmaker receives aggregate results by channel, campaign and partner, including retention at month 3 and month 6. Partners connect once and see their own results, and the partner tools are open to every partner in the program. Curve signs a BAA on every plan, holds SOC 2 Type II, and its team does the setup, typically live in about a week, case by case. See Curve for pharma and medical devices, or book a call to work out cost per patient start for your program.
For the full measurement setup, see direct-to-patient pharma attribution.
Cash starts are often missing from claims; here is why cash-pay patients disappear from claims data.
Cost per patient start is step four of measuring a direct-to-patient program.
Sources, checked November 20, 2026: HealthVerity, January 14, 2026; IQVIA, Why Obesity Requires a New Evidence Paradigm, 2026; L.E.K. Consulting, The Emergence of Direct-to-Consumer Pharmaceutical Platforms, 2026; Digital Medicine Society release, April 16, 2026; Pharmaceutical Commerce, March 26, 2026.
Frequently Asked Questions
What is cost per patient start?
Cost per patient start is ad spend divided by the number of new patients who began therapy in the same period, read by channel, campaign and partner. Here a start means a new patient's first paid fill, a definition each partner should agree before launch.
How is cost per patient start different from cost per paid fill?
Cost per patient start counts each new patient once, at the first paid fill. Cost per paid fill counts every paid fill, refills included, so it falls over time when patients continue on therapy.
Where does the patient start come from in a cash-pay program?
From the pharmacy or telehealth partner that records it, because cash-pay fills often fall outside insurance workflows and can be missing from claims data. A partner can report it through an incoming webhook or a file upload.
Which spend does Curve put next to patient starts?
Meta and Google Ads spend. Campaign Reporting shows it next to Curve-tracked conversions per platform and campaign, with five attribution models.
What does the drugmaker receive?
Aggregate results by channel, campaign and partner, such as starts, paid fills, cost per patient start and cost per paid fill. Partner events carry the step, the time and the campaign reference, with no name or contact details.
Can partners see their own results?
Yes. Each partner connects once and sees its own results, and the partner tools are open to every partner in the program.
How is this different from a clinic's cost per started patient?
A clinic computes it from its own records for its own campaigns. A drugmaker's version combines reports from several telehealth and pharmacy partners, read in aggregate by channel, campaign and partner.
Talk to Curve Compliance
Book a call. Want cost per patient start and cost per paid fill by channel, campaign and partner? Curve's team maps the steps with your partners and does the setup, typically live in about a week, case by case. Book a call with Curve.